LabDays Copenhagen

The Swedish spatial biology startup Haga Bioscience has closed a USD 2.3 million oversubscribed seed financing round bringing total funding, including pre-seed financing, to approximately USD 3 million.

Thålin has been awarded the Swedish Heart-Lung Foundation’s major research grant for her work on antibody-based protection against infections in chronic obstructive pulmonary disease (COPD).

Growing two or three-dimensional human nasal tissue can lead to better reliability in research studies, personalized treatment strategies, and ultimately contribute to better outcomes for patients.

Herantis Pharma provides an update on preparations for the Phase 2a proof-of-concept efficacy study of HER-096, its lead candidate for the treatment of Parkinson's disease.

Stayble Therapeutics has announced that its Board of Directors has resolved to file for bankruptcy, with the application to be submitted to the Gothenburg District Court.

The Helsinki-based AI drug discovery company has paired with a US biotech in rare and metabolic disease.

French pharma company Servier has entered into an agreement to acquire the muscular dystrophy business of US Edgewise Therapeutics for up to USD 2.65 billion, including upfront payment of USD 1.55 billion as well as up to USD1.1 billion in regulatory and commercial milestone payments.